| Reference |
|---|
Abdel Raoof Fouda M, Abdel Wahhab M, Abdelkader A, Ibrahim M, Elsheikh T, Aldeweik H, et al. Effect of gut microbiota changes on cytokines IL-10 and IL-17 levels in liver transplantation patients. BMC Infect Dis. 2025;25:140 pubmed publisher |
Pourfarzam S, Ardestani S, Jamali T, Ghazanfari H, Naghizadeh M, Faghihzadeh S, et al. Distinct inflammatory profiles in mustard lung: A study of sulfur mustard-exposed patients with serious pulmonary complications. Int Immunopharmacol. 2025;146:113832 pubmed publisher |
Tucker R, Kim N, Gurzell E, Mathi S, Chavva S, Senthilkumar D, et al. Commonly Used Dose of Montmorency Tart Cherry Powder Does Not Improve Sleep or Inflammation Outcomes in Individuals with Overweight or Obesity. Nutrients. 2024;16: pubmed publisher |
Shepelkova G, Evstifeev V, Berezovskiy Y, Ergeshova A, Tarasov R, Bagirov M, et al. Characteristics of Pulmonary Inflammation in Patients with Different Forms of Active Tuberculosis. Int J Mol Sci. 2024;25: pubmed publisher |
Joci x107 J, Lu x10d i x107 A, Jovanovi x107 I, Juri x161 evi x107 M, Stanisavljevi x107 I, Stamenkovi x107 B, et al. Interleukin 41 As A Potential Predictor of Bio-Therapy Efficacy In Patients With Rheumatoid Arthritis: A Prospective Observational Study. Int J Med Sci. 2024;21:2518-2524 pubmed publisher |
Chen K, Sun W, Wu S, Feng P, Lin C, Chen T, et al. Reduced Tolerogenic Program Death-Ligand 1-Expressing Conventional Type 1 Dendritic Cells Are Associated with Rapid Decline in Chronic Obstructive Pulmonary Disease. Cells. 2024;13: pubmed publisher |
Bo x142 kun x, Starosz A, Kr x119 towska Grunwald A, Wasiluk T, Walewska A, Wierzbowska A, et al. Effects of Combinatory In Vitro Treatment with Immune Checkpoint Inhibitors and Cytarabine on the Anti-Cancer Immune Microenvironment in De Novo AML Patients. Cancers (Basel). 2024;16: pubmed publisher |
Kr x119 towska Grunwald A, Sawicka x17b ukowska M, Kowalska M, Basaj A, Krawczuk Rybak M, Moniuszko M, et al. Significance of Th17 and Treg in Treatment Efficacy and Outcome in Pediatric Acute Lymphoblastic Leukemia. Int J Mol Sci. 2023;24: pubmed publisher |
Fiorillo A, Gallego J, Casanova Ferrer F, Gim xe9 nez Garz xf3 C, Urios A, Ballester M, et al. Mild Cognitive Impairment Is Associated with Enhanced Activation of Th17 Lymphocytes in Non-Alcoholic Fatty Liver Disease. Int J Mol Sci. 2023;24: pubmed publisher |
Teufel L, van der Made C, Kl xfc ck V, Simons A, Hoischen A, Vernimmen V, et al. Effect of exogenous IL-37 on immune cells from a patient carrying a potential IL37 loss-of-function variant: A case study. Cytokine. 2023;162:156102 pubmed publisher |
Park J, Yang S, Jeong H, Lee S, Ryu J, Choi J, et al. EC-18 prevents autoimmune arthritis by suppressing inflammatory cytokines and osteoclastogenesis. Arthritis Res Ther. 2022;24:254 pubmed publisher |
Reverchon F, Guillard C, Mollet L, Auzou P, Gosset D, Madouri F, et al. T Lymphocyte Serotonin 5-HT7 Receptor Is Dysregulated in Natalizumab-Treated Multiple Sclerosis Patients. Biomedicines. 2022;10: pubmed publisher |
Sharif Askari F, Sharif Askari N, Hafezi S, Mdkhana B, Alsayed H, Ansari A, et al. Interleukin-17, a salivary biomarker for COVID-19 severity. PLoS ONE. 2022;17:e0274841 pubmed publisher |
Rossi F, Maldonado A, Cholewa J, Ribeiro S, de Ara xfa jo Barros C, Figueiredo C, et al. Exercise training-induced changes in immunometabolic markers in youth badminton athletes. Sci Rep. 2022;12:15539 pubmed publisher |
Kartasheva Ebertz D, Gaston J, Lair Mehiri L, Mottez E, Buivan T, Massault P, et al. IL-17A in Human Liver: Significant Source of Inflammation and Trigger of Liver Fibrosis Initiation. Int J Mol Sci. 2022;23: pubmed publisher |
Hu J, Zhang Y, Yi S, Wang C, Huang X, Pan S, et al. Lithocholic acid inhibits dendritic cell activation by reducing intracellular glutathione via TGR5 signaling. Int J Biol Sci. 2022;18:4545-4559 pubmed publisher |
Minuzzi L, Lira F, de Poli R, Fialho Lopes V, Zagatto A, Suzuki K, et al. High-intensity intermittent exercise induces a potential anti-inflammatory response in healthy women across the menstrual cycle. Cytokine. 2022;154:155872 pubmed publisher |
Szylar G, Wysoczanski R, Marshall H, Marks D, Jose R, Ehrenstein M, et al. A novel Streptococcus pneumoniae human challenge model demonstrates Treg lymphocyte recruitment to the infection site. Sci Rep. 2022;12:3990 pubmed publisher |
Schmitt A, Puppa M, Wessels I, Rink L. Vitamin D3 and zinc synergistically induce regulatory T cells and suppress interferon-γ production in mixed lymphocyte culture. J Nutr Biochem. 2022;102:108942 pubmed publisher |
Holl J, Pawlukianiec C, Corton Ruiz J, Groth D, Grubczak K, Hady H, et al. Skin Substitute Preparation Method Induces Immunomodulatory Changes in Co-Incubated Cells through Collagen Modification. Pharmaceutics. 2021;13: pubmed publisher |
Mathiasen S, Gall Mas L, Pateras I, Theodorou S, Namini M, Hansen M, et al. Bacterial genotoxins induce T cell senescence. Cell Rep. 2021;35:109220 pubmed publisher |
Costa F, Leite J, Rassi D, da Silva J, Elias Oliveira J, Guimar xe3 es J, et al. NLRP1 acts as a negative regulator of Th17 cell programming in mice and humans with autoimmune diabetes. Cell Rep. 2021;35:109176 pubmed publisher |
Wang P, Killeen M, Sumpter T, Ferris L, Falo L, Freeman B, et al. Electrophilic nitro-fatty acids suppress psoriasiform dermatitis: STAT3 inhibition as a contributory mechanism. Redox Biol. 2021;43:101987 pubmed publisher |
Lee P, Yang T, Chen K, Huang Y, Tseng J, Hsu K, et al. Higher CD4/CD8 ratio of pleural effusion predicts better survival for lung cancer patients receiving immune checkpoint inhibitors. Sci Rep. 2021;11:9381 pubmed publisher |
Madeira R, Dal Mas Romera L, de Cássia Buck P, Mady C, Ianni B, Torrecilhas A. New Biomarker in Chagas Disease: Extracellular Vesicles Isolated from Peripheral Blood in Chronic Chagas Disease Patients Modulate the Human Immune Response. J Immunol Res. 2021;2021:6650670 pubmed publisher |
Luban J, Sattler R, Mühlberger E, Graci J, Cao L, Weetall M, et al. The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines. Virus Res. 2021;292:198246 pubmed publisher |
De M, Bhushan A, Chinnaswamy S. Monocytes differentiated into macrophages and dendritic cells in the presence of human IFN-λ3 or IFN-λ4 show distinct phenotypes. J Leukoc Biol. 2020;: pubmed publisher |
Rahat M, Safieh M, Simanovich E, Pasand E, Gazitt T, Haddad A, et al. The role of EMMPRIN/CD147 in regulating angiogenesis in patients with psoriatic arthritis. Arthritis Res Ther. 2020;22:240 pubmed publisher |
Collin A, Lecocq M, Noel S, Detry B, Carlier F, Aboubakar Nana F, et al. Lung immunoglobulin A immunity dysregulation in cystic fibrosis. EBioMedicine. 2020;60:102974 pubmed publisher |
Britton G, Chen Liaw A, Cossarini F, Livanos A, Spindler M, Plitt T, et al. SARS-CoV-2-specific IgA and limited inflammatory cytokines are present in the stool of select patients with acute COVID-19. medRxiv. 2020;: pubmed publisher |
Maekawa T, Tamura H, Domon H, Hiyoshi T, Isono T, Yonezawa D, et al. Erythromycin inhibits neutrophilic inflammation and mucosal disease by upregulating DEL-1. JCI Insight. 2020;5: pubmed publisher |
Ryu J, Jhun J, Park M, Baek J, Kim S, Cho K, et al. FTY720 ameliorates GvHD by blocking T lymphocyte migration to target organs and by skin fibrosis inhibition. J Transl Med. 2020;18:225 pubmed publisher |
Herrera M, Vera C, Keynan Y, Rueda Z. Gaps in Study Design for Immune Parameter Research for Latent Tuberculosis Infection: A Systematic Review. J Immunol Res. 2020;2020:8074183 pubmed publisher |
Kim H, Baek S, Hong S, Lee J, Jung S, Lee J, et al. 1,25-dihydroxy Vitamin D3 and Interleukin-6 Blockade Synergistically Regulate Rheumatoid Arthritis by Suppressing Interleukin-17 Production and Osteoclastogenesis. J Korean Med Sci. 2020;35:e40 pubmed publisher |
Losada P, Perdomo Celis F, Castro M, Salcedo C, Salcedo A, DeLaura I, et al. Locally-secreted interleukin-6 is related with radiological severity in smear-negative pulmonary tuberculosis. Cytokine. 2020;127:154950 pubmed publisher |
Qi J, Du L, Deng J, Qin Y, Su G, Hou S, et al. Replication of Genome-Wide Association Analysis Identifies New Susceptibility Loci at Long Noncoding RNA Regions for Vogt-Koyanagi-Harada Disease. Invest Ophthalmol Vis Sci. 2019;60:4820-4829 pubmed publisher |
Martinez Hervas S, SÁnchez GarcÍa V, Herrero Cervera A, Vinue A, Real J, Ascaso J, et al. Type 1 diabetic mellitus patients with increased atherosclerosis risk display decreased CDKN2A/2B/2BAS gene expression in leukocytes. J Transl Med. 2019;17:222 pubmed publisher |
Lopatina T, Favaro E, Grange C, Cedrino M, Ranghino A, Occhipinti S, et al. PDGF enhances the protective effect of adipose stem cell-derived extracellular vesicles in a model of acute hindlimb ischemia. Sci Rep. 2018;8:17458 pubmed publisher |
Yi S, Chang R, Hu J, Qiu Y, Wang Q, Cao Q, et al. Disabled-2 (DAB2) Overexpression Inhibits Monocyte-Derived Dendritic Cells' Function in Vogt-Koyanagi-Harada Disease. Invest Ophthalmol Vis Sci. 2018;59:4662-4669 pubmed publisher |
Zhang Q, Li H, Hou S, Yu H, Su G, Deng B, et al. Association of genetic variations in PTPN2 and CD122 with ocular Behcet's disease. Br J Ophthalmol. 2018;102:996-1002 pubmed publisher |
Tsai H, Velichko S, Lee S, Wu R. Cholera toxin enhances interleukin-17A production in both CD4+ and CD8+ cells via a cAMP/protein kinase A-mediated interleukin-17A promoter activation. Immunology. 2018;154:500-509 pubmed publisher |
Manetti M, Pratesi S, Romano E, Bellando Randone S, Rosa I, Guiducci S, et al. Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis. PLoS ONE. 2017;12:e0183102 pubmed publisher |
Oke V, Brauner S, Larsson A, Gustafsson J, Zickert A, Gunnarsson I, et al. IFN-?1 with Th17 axis cytokines and IFN-? define different subsets in systemic lupus erythematosus (SLE). Arthritis Res Ther. 2017;19:139 pubmed publisher |
Saleh A, Chalmers J, De Soyza A, Fardon T, Koustas S, Scott J, et al. The heterogeneity of systemic inflammation in bronchiectasis. Respir Med. 2017;127:33-39 pubmed publisher |
Snelling S, Bas S, Puskas G, Dakin S, Suva D, Finckh A, et al. Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype. PLoS ONE. 2017;12:e0175109 pubmed publisher |
Kathamuthu G, Moideen K, Baskaran D, Banurekha V, Nair D, Sekar G, et al. Tuberculous Lymphadenitis Is Associated with Enhanced Baseline and Antigen-Specific Induction of Type 1 and Type 17 Cytokines and Reduced Interleukin-1? (IL-1?) and IL-18 at the Site of Infection. Clin Vaccine Immunol. 2017;24: pubmed publisher |
Yang Y, Wang Q, Xie M, Liu P, Qi X, Liu X, et al. Berberine exerts an anti-inflammatory role in ocular Behcet's disease. Mol Med Rep. 2017;15:97-102 pubmed publisher |
Noack M, Ndongo Thiam N, Miossec P. Interaction among activated lymphocytes and mesenchymal cells through podoplanin is critical for a high IL-17 secretion. Arthritis Res Ther. 2016;18:148 pubmed publisher |
Qin J, Li L, Zhang D, Yu H, Tan H, Zhang J, et al. Analysis of receptor tyrosine kinase genetics identifies two novel risk loci in GAS6 and PROS1 in Behçet's disease. Sci Rep. 2016;6:26662 pubmed publisher |
Malecka A, Wang Q, Shah S, Sutavani R, Spendlove I, Ramage J, et al. Stromal fibroblasts support dendritic cells to maintain IL-23/Th17 responses after exposure to ionizing radiation. J Leukoc Biol. 2016;100:381-9 pubmed publisher |
El Azreq M, Arseneault C, Boisvert M, Pagé N, Allaeys I, Poubelle P, et al. Cooperation between IL-7 Receptor and Integrin α2β1 (CD49b) Drives Th17-Mediated Bone Loss. J Immunol. 2015;195:4198-209 pubmed publisher |
Jiang Z, Hennein L, Tao Y, Tao L. Interleukin-23 Receptor Gene Polymorphism May Enhance Expression of the IL-23 Receptor, IL-17, TNF-α and IL-6 in Behcet's Disease. PLoS ONE. 2015;10:e0134632 pubmed publisher |
Mora D, Fortunato L, Andrade Silva L, Ferreira Paim K, Rocha I, Vasconcelos R, et al. Cytokine profiles at admission can be related to outcome in AIDS patients with cryptococcal meningitis. PLoS ONE. 2015;10:e0120297 pubmed publisher |
Zhang Q, Qi J, Hou S, Du L, Yu H, Cao Q, et al. A functional variant of PTPN22 confers risk for Vogt-Koyanagi-Harada syndrome but not for ankylosing spondylitis. PLoS ONE. 2014;9:e96943 pubmed publisher |
Sun M, Yang P, Du L, Yang Y, Ye J. The role of interleukin-1 receptor-associated kinases in Vogt-Koyanagi-Harada disease. PLoS ONE. 2014;9:e93214 pubmed publisher |
Bollinger T, Gies S, Naujoks J, Feldhoff L, Bollinger A, Solbach W, et al. HIF-1?- and hypoxia-dependent immune responses in human CD4+CD25high T cells and T helper 17 cells. J Leukoc Biol. 2014;96:305-12 pubmed publisher |
Arndts K, Specht S, Debrah A, Tamarozzi F, Klarmann Schulz U, Mand S, et al. Immunoepidemiological profiling of onchocerciasis patients reveals associations with microfilaria loads and ivermectin intake on both individual and community levels. PLoS Negl Trop Dis. 2014;8:e2679 pubmed publisher |
Prigent L, Robineau M, Jouneau S, Morzadec C, Louarn L, Vernhet L, et al. The aryl hydrocarbon receptor is functionally upregulated early in the course of human T-cell activation. Eur J Immunol. 2014;44:1330-40 pubmed publisher |
Evans H, Roostalu U, Walter G, Gullick N, Frederiksen K, Roberts C, et al. TNF-? blockade induces IL-10 expression in human CD4+ T cells. Nat Commun. 2014;5:3199 pubmed publisher |
Cui F, Meng J, Luo P, Chen P. IFN- alpha blocks IL-17 production by peripheral blood mononuclear cells in patients with chronic active hepatitis B Infection. BMC Infect Dis. 2014;14:55 pubmed publisher |
Cheng K, Wong S, Linn Y, Ho L, Chng W, Schwarz H. CD137 ligand signalling induces differentiation of primary acute myeloid leukaemia cells. Br J Haematol. 2014;165:134-44 pubmed publisher |
Fitzgerald D, Fonseca Kelly Z, Cullimore M, Safabakhsh P, Saris C, Zhang G, et al. Independent and interdependent immunoregulatory effects of IL-27, IFN-?, and IL-10 in the suppression of human Th17 cells and murine experimental autoimmune encephalomyelitis. J Immunol. 2013;190:3225-34 pubmed publisher |
Sato W, Tomita A, Ichikawa D, Lin Y, Kishida H, Miyake S, et al. CCR2(+)CCR5(+) T cells produce matrix metalloproteinase-9 and osteopontin in the pathogenesis of multiple sclerosis. J Immunol. 2012;189:5057-65 pubmed publisher |
Arndts K, Deininger S, Specht S, Klarmann U, Mand S, Adjobimey T, et al. Elevated adaptive immune responses are associated with latent infections of Wuchereria bancrofti. PLoS Negl Trop Dis. 2012;6:e1611 pubmed publisher |
van de Veerdonk F, Stoeckman A, Wu G, Boeckermann A, Azam T, Netea M, et al. IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist. Proc Natl Acad Sci U S A. 2012;109:3001-5 pubmed publisher |
Chu M, Yang P, Hu R, Hou S, Li F, Chen Y, et al. Elevated serum osteopontin levels and genetic polymorphisms of osteopontin are associated with Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci. 2011;52:7084-9 pubmed publisher |
Jiang S, Liu X, Luo L, Qu B, Huang X, Lin Y, et al. Serum levels of Th17-related cytokines in Behcet disease patients after cataract surgery. Mol Vis. 2011;17:1425-30 pubmed |
Sweeney C, Lonergan R, Basdeo S, Kinsella K, Dungan L, Higgins S, et al. IL-27 mediates the response to IFN-? therapy in multiple sclerosis patients by inhibiting Th17 cells. Brain Behav Immun. 2011;25:1170-81 pubmed publisher |
Yu R, Gallagher G. A naturally occurring, soluble antagonist of human IL-23 inhibits the development and in vitro function of human Th17 cells. J Immunol. 2010;185:7302-8 pubmed publisher |
Liu X, Yang P, Wang C, Li F, Kijlstra A. IFN-alpha blocks IL-17 production by peripheral blood mononuclear cells in Behcet's disease. Rheumatology (Oxford). 2011;50:293-8 pubmed publisher |
Jones G, Stumhofer J, Foster T, Twohig J, Hertzog P, Topley N, et al. Naive and activated T cells display differential responsiveness to TL1A that affects Th17 generation, maintenance, and proliferation. FASEB J. 2011;25:409-19 pubmed publisher |
Aliahmadi E, Gramlich R, Grützkau A, Hitzler M, Krüger M, Baumgrass R, et al. TLR2-activated human langerhans cells promote Th17 polarization via IL-1beta, TGF-beta and IL-23. Eur J Immunol. 2009;39:1221-30 pubmed publisher |
Eid R, Rao D, Zhou J, Lo S, Ranjbaran H, Gallo A, et al. Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation. 2009;119:1424-32 pubmed publisher |
Johansen C, Usher P, Kjellerup R, Lundsgaard D, Iversen L, Kragballe K. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin. Br J Dermatol. 2009;160:319-24 pubmed publisher |
Chen L, Yang P, Zhou H, He H, Ren X, Chi W, et al. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome. Invest Ophthalmol Vis Sci. 2008;49:3475-82 pubmed publisher |
Sato W, Aranami T, Yamamura T. Cutting edge: Human Th17 cells are identified as bearing CCR2+CCR5- phenotype. J Immunol. 2007;178:7525-9 pubmed |
Meyers J, Mangini A, Nagai T, Roff C, Sehy D, van Seventer G, et al. Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine IFN-gamma and IL-17 secretion by activated human PBMC. Cytokine. 2006;35:235-46 pubmed |
Miranda Carús M, Balsa A, Benito Miguel M, Pérez de Ayala C, Martin Mola E. IL-15 and the initiation of cell contact-dependent synovial fibroblast-T lymphocyte cross-talk in rheumatoid arthritis: effect of methotrexate. J Immunol. 2004;173:1463-76 pubmed |
